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Abstract 
Accelerated fracture healing in patients with spinal cord injuries (SCI) is often 
encountered in clinical practice. However, there is no distinct evidence in the 
accelerated fracture healing, and the mechanisms of accelerated fracture healing in SCI 
are poorly understood. We aimed to determine whether SCI accelerated fracture healing 
in morphology and strength, to characterize the healing process with SCI, and to clarify 
the factors responsible for accelerated fracture healing. In total, 39 male Wistar rats 
were randomly divided into healthy control without intervention, SCI only, fracture with 
SCI, botulinum toxin (BTX) A-treated fracture with SCI, and propranolol-treated 
fracture with SCI groups. These rats were assessed with computed 
microtomography, histological, histomorphological, immunohistological, and 
biomechanical analyses. Both computed microtomography and histological analyses 
revealed the acceleration of a bony union in animals with SCI. The strength of the 
healed fractures after SCI recovered to the same level as that of intact bones after SCI, 
while the healed bones were weaker than the intact bones. Immunohistology revealed 
that SCI fracture healing was characterized by formation of callus with predominant 
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intramembranous ossification and promoting endochondral ossification. The accelerated 
fracture healing after SCI was attenuated by BTX injection, but did not change by 
propranolol. We demonstrated that SCI accelerate fracture healing in both morphology 
and strength. The accelerated fracture healing with SCI may be due to predominant 
intramembranous ossification and promoting endochondral ossification. In addition, our 
results also suggest that muscle contraction by spasticity accelerates fracture healing 
after SCI.  
 
Keywords 
Spinal cord injuries, Fracture healing, Acceleration, Endochondral ossification, 
Intramembranous ossification, Botulinum toxin A  
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Introduction 
Spinal cord injuries (SCI) cause paralysis of motor and sensory control at regions below 
the neurological lesion. Muscle atrophy [1], joint contracture [2], and bone disease [3-5] 
are the major complications of SCI in the sublesional area. Among SCI patients, more 
than 50% have developed bone disease, including bone atrophy, heterotopic 
ossification, and fractures [6]. In particular, fracture is a prevalent complication of SCI, 
and in clinical settings, the fracture associated with SCI tends to heal quickly. This 
phenomenon has been demonstrated by some clinical studies [5, 7]. These findings 
inspired us to investigate the process of fracture healing with SCI.  
 To our knowledge, 7 animal studies have investigated the effects of SCI on 
fracture healing. Three studies [8-10] have shown that fracture healing was delayed 
after SCI, when fractured at 2 or 3 weeks after SCI. In contrast, the remaining four 
studies, which examined the fracture coincided with SCI, have showed early bony 
bridging [11], enhanced callus formation [12], enhanced callus ossification [13, 14], and 
accelerated endochondral ossification [11]; then these findings indicate that SCI led to 
accelerated fracture healing. However, this evidence is based on the results observed in 
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rats from 0 to 28 days after the fracture, except one sample of 56 days after the fracture 
reported by Aro et al. [13]. Regardless, normal fracture healing takes 35-42 days to 
achieve complete healing in rats [15]. Considering the research as a whole, little is 
known about the process of restoration to the bone’s original shape and structure from 
the fractures with SCI. Unfortunately, the radiographic analysis and qualitative 
histological evaluation used in earlier studies [13] lack the discriminative power and 
quantitative properties that would enable a distinct differentiation between normal and 
SCI fracture healing. Furthermore, the most meaningful clinical assessment of fracture 
healing is the return of the mechanical strength of the healed bone. However, the 
mechanical strength of the healed bone after SCI has not been evaluated.  
 An intriguing question that arises from these studies is what is contributing to 
the acceleration of fracture healing with SCI. Spasticity [16] and autonomic 
hyperreflexia [17] are a representative complication of SCI. Spasticity produces 
hypertonicity when the spastic muscle continuously contracts. Muscular contraction 
induced by electrical stimulation improves bone atrophy [18], whereas hypertonia with 
botulinum injections impairs fracture healing [19]. Thus, mechanical stress by muscular 
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contraction may have impact on fracture healing. On the other hand, autonomic 
hyperreflexia leads to increased sympathetic activity. Recently, there have been many 
reports concerning participation of sympathetic nervous system in regulating bone 
metabolism [20-23]. Although its physiologic mechanism remains to be elucidated at 
present, increased sympathetic activity unequivocally affects bone metabolism.  
 The objectives of this paper were to determine whether SCI result in 
accelerated fracture healing in bone structure and mechanical strength and to 
characterize the process of accelerated fracture healing with SCI. Furthermore, we 
assessed the contribution of the spasticity or autonomic hyperreflexia that is suspected 
to be the cause to accelerated fracture healing after SCI.  
 
Materials and Methods  
Experimental Design  
All experimental procedures were examined by the Institutional Animal Care and Use 
Committee, approved by the president of Kobe University, and performed according to 
the Kobe University Animal Experimentation Regulations. A total of 39 male Wistar 
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rats (16 weeks old, 380-400 g mean body weight, Japan SLC Inc., Japan) were used for 
this study. Male rats aged 16 weeks were chosen to avoid the effects of estrogen [24] 
and rapid growth [25] to bone. Animals were housed in pairs in standard cages under a 
12h dark/light cycle at a constant temperature of 22 ± 1 °C and allowed free access to 
standard food and water. These rats were randomly divided into a healthy control group 
that had no intervention (control group), non-fractured spinal cord injuries (SCI group), 
fracture group, and fracture with SCI (fracture + SCI group). In addition, to assess the 
contribution of the spasticity, botulinum toxin (BTX)-A was injected into muscles 
surrounding the fracture line after fracture with SCI (BTX group), and to eliminate the 
sympathetic overactivity effect, the -adrenergic antagonist, propranolol, was 
administered intraperitoneally after fracture with SCI (propranolol group). The right and 
left femurs of each animal served as different samples. Total 78 femurs were assessed 
by synchrotron radiation computed microtomography (SR-µCT), µCT, histological 
analysis, histomorphometric analysis, immunohistochemical analysis, and mechanical 
testing. For SR-µCT, histological analysis, histomorphometric analysis, and 
immunohistochemical analysis, we compared the fracture + SCI group with the fracture 
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group at 7, 14, 28, and 49 days after fracture (n = 6 limbs at each time point). The BTX 
and propranolol groups were assessed with µCT and histological analysis at 14 and 28 
days after fracture. For mechanical testing, in addition to, the control, SCI, fracture, and 
fracture + SCI groups at 49 days were used (n = 4 femurs in all of the groups). The 
study design including the assignment of animals to respective groups is shown in 
supplemental Fig. 1. The sample sizes were calculated by a power analysis with a level 
of 0.80 based on pilot results.  
Animal Model  
Spinal Cord-Injured Model  
The SCI surgeries conformed to the protocols in our previous studies [26-30] with a 
slight modification. The animals were anesthetized with pentobarbital sodium (40 mg/ 
kg, intraperitoneally) and buprenorphine [0.02 mg/kg, subcutaneously (s.c.)]. A midline 
incision was made through the skin in the distal thoracic area. The lateral paraspinal 
muscles were dissected along either side of the spinous processes, and the dorsal surface 
of vertebras from T7 to T11 was exposed. The spinal cord, which was completely 
transected at the level, was exposed by a laminectomy of the vertebras from T7 to T8. 
8  
Finally, the muscle and the skin were closed separately with silk sutures.  
Closed Mid-Shaft Femoral Fracture Model  
After SCI, the closed mid-shaft femoral fracture was produced in the bilateral femurs of 
the rat in fracture, fracture + SCI, BTX, and propranolol groups using the protocols of 
Bonnarens and Einhorn [31]. The skin over the knee joint was incised longitudinally. 
The patella was dislocated on the lateral side, and the articular surface of the femoral 
condyle was exposed. A Kirschner wire (k-wire) was inserted into the femoral canal 
from the intercondylar notch as an intramedullary nailing fixation. The k-wire was cut, 
and the patella dislocation was reduced. The joint capsule and the skin were closed. 
Afterward, the closed mid-shaft femoral fracture was created with a 3-point bending 
apparatus composed of a blunt guillotine driven by a dropped weight.  
Pharmaceutical Intervention  
For the BTX group, 1 UI/ml solution of BTX-A was prepared by dissolving BTX-A in 
0.9% saline solution. BTX-A solution was injected into both femoral regions 
(quadriceps, biceps, and adductor magnus) of rats in BTX group after fracture. This 
dose of BTX-A per muscle has previously been shown to produce muscle relaxant for 
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28 days [32].  
 To reduce sympathetic overactivities in SCI rats, the rats of propranolol group 
were received a single daily intraperitoneal injections of propranolol (20 mg/kg/day) 
between 8:00 and 9:00 P.M. Dose and treatment protocol were based upon those 
described by Kondo and Togari [33] and Minkowitz et al. [34]. These methods have 
proven for inhibition of sympathetic activity with cardiac function analysis [35].  
Postoperative Care  
An analgesic (buprenorphine, 0.02 mg/kg, s.c.) was administered twice daily for 3 days 
after the surgery. Postoperatively, the bladders of SCI rats were manually compressed 
three times daily for 2 weeks and then twice daily until each time point.  
Sampling  
All rats were killed by exsanguination under anesthesia and analgesia at each time 
point. The femurs were harvested and the muscle tissues were removed from the bone. 
Then, we measured the callus dimensions in the anteroposterior and lateral dimensions 
at the fracture line using an electronic caliper (CD-S20C, Mitutoyo, Japan), and the 
overall callus size was the mean of these two dimensions. After measuring the callus 
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size, the femurs were immediately frozen and stored at -80 °C until analyzed.  
µCT  
We used a high-resolution computed tomography (CT) system installed in the beamline 
20B2 of the synchrotron radiation facility Spring-8 (Harima, Japan). The femur of rats 
in the fracture and fracture + SCI groups was mounted on a stack of the computer-
controlled precision stage. The photon flux transmitted through the sample was detected 
by a high-resolution detector consisting of a beam monitor (AA60, Hamamatsu 
Photonics, Hamamatsu, Japan) and a cooled charge-coupled device camera (ORCA-
flash 4.0, Hamamatsu Photonics, Hamamatsu, Japan) at 25 keV. The samples were 
scanned with 8.03 µm voxel size. The region of interest was defined as the fractured 
line on the center and the upper and lower 15 mm. The femur of rats in the BTX and 
propranolol groups was imaged using µCT (R_mCT2, Rigaku, Tokyo, Japan). The 
samples were scanned with 20 µm voxel size. The region of interest was defined as the 
fractured line on the center and the upper and lower 10 mm. Three-dimensional 
reconstructions of the images were visualized with ImageJ 1.38 (ImageJ, NIH, USA). 
To distinguish mineralized and non-mineralized tissues, the thresholding values were set 
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at 641.9 mg HA/cm3.  
Histology  
Tissue Preparation for Histology  
We prepared undecalcified frozen sections as previously described in the literature [36]. 
The bones were embedded in super cryoembedding medium (SCEM, Section-lab, 
Japan). Each sample was sectioned at a thickness of 5 µm with a disposable tungsten 
carbide blade at a central point in the bone (5 sections per a sample). Four samples from 
each group were used for histological, histomorphometric, or immunohistochemical 
analyses.  
Histological and Histomorphometric Analyses  
Frozen sections were stained with safranin-O-fast green. They were captured with a 
light microscope (BX-53, Olympus, Japan) at a magnification of ×4. The degree of 
fracture healing was evaluated using the 5-point scale following the method described 
by Allen et al. [37]. The histomorphometric parameter was measured as described by 
Colnot [38]. Briefly, the areas of fibrous tissue, cartilage tissue, and newly formed bone 
tissue were assessed as a percentage of the total callus area with Adobe Photoshop CS 
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(Adobe Systems Inc., Japan).  
Immunohistochemical Analysis  
The frozen sections were incubated with mouse monoclonal anti-collagen Type I 
(diluted 1: 4000, C2456, Sigma-Aldrich, USA), mouse monoclonal anti-collagen Type 
II (diluted 1: 1000, F57, Daiichi Fine Chemical, Japan), rabbit polyclonal anti-collagen 
Type X (diluted 1: 1000, LB-0092, LSL, Japan), or mouse monoclonal anti-CD68 
(diluted 1: 2000, MCA341GA, Serotec, UK) antibodies. A subsequent reaction was 
made using the strep-tavidin-biotin-peroxidase complex technique with an Elite ABC 
kit (diluted 1: 50, PK-610, Vector Laboratories, USA). Then, the 3,30-diaminobenzidine 
tetrahydrochloride (K3466, Dako Japan, Japan) was used for the visualization of the 
immunoreaction. The sections were finally counterstained with hematoxylin, washed in 
water, and coverslipped. They were captured with a light microscope (BX-53, Olympus, 
Japan) at a magnification of ×4. Type I, II, and X collagen-positive areas were 
measured as a percentage of total callus area with Adobe Photoshop CS (Adobe 
Systems Inc., Japan).  
Mechanical Testing  
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The k-wire was removed, and the femurs were thawed to room temperature for 2 h. The 
functional mechanical properties of the bone were then assessed by a 3-point bending 
test with a load torsion and bending tester (AUTOGRAPH, Shimazu, Japan). The 
sample was placed on supports located at a distance of 20 mm. The bending force was 
applied midway between the supports on the anterior surface at a speed of 2 mm/min 
until the fracture occurred. During the mechanical testing, load-deflection data were 
recorded. The load-deflection curve provided the biomechanical parameters as follows: 
ultimate loads at failure (the maximum force endured by femur), stiffness (the slope of 
the linear portion of the curve), and energy-to-failure (the area under the curve).  
Statistical Analysis  
The results of the callus size, histomorphometric analysis, and mechanical testing are 
presented as the mean ± standard deviation (SD), and the degree of fracture healing is 
presented as the median (25-75%). All statistical analyses were performed using SPSS 
22 for Mac (SPSS Japan, Japan). A Student’s t test was used to compare the callus size 
or histomorphometric analysis between the fracture and fracture + SCI groups at each 
time point. A one-way ANOVA assessed the differences between all groups for 
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mechanical testing with a Tukey’s test. The Mann-Whitney U test was applied to 
compare the degree of fracture healing between the fracture and fracture + SCI groups 
at each time point. An alpha value less than 0.05 was chosen as the significance level 
for these statistical analyses.  
 
Results  
General Observations  
All of the rats survived throughout the experimental period, were active, and appeared 
healthy except for hindlimb functional deficits associated with SCI such as the motor 
paralysis and sensory paralysis. The body weight of the fracture + SCI rats tended to be 
lower than that of fracture rats at all time points (325.0 ± 30.6 vs. 354.3 ± 14.7 g at 7 
days; 295.3 ± 44.1 vs. 381.3 ± 3.1 g at 14 days; 356.3 ± 6.1 vs. 375.0 ± 22.2 g at 28 
days; 369.6 ± 20.1 vs. 442.6 ± 23.1 g at 49 days); however, fracture + SCI rats gained 
weight after 14 days, indicating general good health.  
 The response to stimuli disappeared, and rats of SCI, fracture + SCI, BTX, 
and propranolol groups demonstrated complete flaccid paraplegia during the first few 
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days after the injury, and thereafter showed kick movements, clonic and high-frequency 
flexion-extension movements, and hyperreflexive response which were defined as 
spasticity [39]. The rats in BTX group showed the reflex response to stimuli, but the 
kick movements were not observed. These results indicated that the dose of BTX in our 
study was adequate to inhibit spasticity after SCI.  
µCT 
Representative 3D images in each group are presented in Fig. 1. At 7 and 14 days, the 
fracture gap was observed in the fracture and fracture + SCI groups. At 28 days, the 
fracture + SCI group exhibited bony bridging of the fractured bone ends, while the 
fracture group did not exhibit bony bridging. At 49 days, the cortices had completely 
bridged in both the groups. On the other hand, the fracture gap in both BTX and 
propranolol groups was clearly observed at 14 days, and then the bony union was 
observed in both the groups at 28 days. 
Callus Size  
The callus size measurements indicated significant differences between the fracture and 
fracture + SCI groups at all the time points (7.91 ± 0.82 vs. 4.93 ± 0.37 mm at 7 days; 
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7.91 ± 0.82 vs. 6.50 ± 0.63 mm at 14 days; 7.90 ± 0.48 vs. 5.73 ± 0.69 mm at 28 days; 
6.14 ± 0.89 vs. 4.92 ± 0.57 mm at 49 days; p < 0.05) (Fig. 2). These results indicated 
that the fractured bone of SCI rats formed a smaller callus than that of the fractured rats 
at all of the time points.  
Fracture Healing Score 
The median value of fracture healing scores at 7 days was significantly lower in the 
fracture + SCI group than in the fracture group [fracture + SCI, 0 (0–0) vs. fracture, 1 
(1–1), p < 0.05]. However, at 14 days the fracture healing score revealed the same 
degree of fracture healing [fracture + SCI, 1 (1–1) vs. fracture, 1 (1–1.25), n.s.]. At 28 
days, the degree of fracture healing was significantly  
higher in the fracture + SCI group than that in the fracture group (fracture + SCI, 4 (4–
4) vs. fracture, 3.5 (3–4), p < 0.05). Moreover, no significant differences were found 
between the groups at 49 days [fracture + SCI, 4 (4–4) vs. fracture, 4 (4–4), n.s.].  
Histology and Histomorphometry  
At 7 days after the fracture, cartilage tissue was undetected and slight woven bone was 
formed beneath the periosteum at the fracture site in the fracture + SCI group, whereas 
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woven bone and cartilage tissue were observed at the fracture region in the fracture 
group. At 7 days after fracture, the cartilage area in the fracture + SCI group was 
significantly smaller than that in the fracture group (p < 0.05) (Fig. 3b). At 14 days, 
woven bone and cartilage tissue were observed, bony bridging was undetected at the 
fracture area, and the fracture gaps still existed in fracture and fracture + SCI groups. At 
28 days, the fracture + SCI group exhibited a bony bridge that consisted of cortical bone 
and slight woven bone. On the other hand, the fracture group had a bony bridge that 
consisted of woven bone. At 49 days, cortical bone bridged the fracture gap in the 
fracture + SCI group, while cortical bridging occurred with slight woven bone in the 
fracture group. 
 The morphology of fracture healing callus was not different in fracture + SCI 
rats with or without BTX at 14 days. At 28 days, the fracture + SCI group exhibited a 
bony bridge that consisted of cortical bone and slight woven bone; however, the BTX 
group had a bony bridge that consisted of woven bone (Fig. 4). The propranolol 
treatment did not affect the histology of fracture healing after SCI at 14 and 28 days 
(Fig. 4).  
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Immunohistochemistry  
At 7 days, only type I collagen immunostaining was detected [4 out of 4 samples were 
positive. The positive area was 15.0 ± 6.3%. The area was smaller than that of fracture 
group (p < 0.01)], but neither type II [2 out of 4 samples were negative. The positive 
area was 1.1 ± 1.6%. The area of fracture + SCI group was smaller than that of fracture 
group (p < 0.01)] nor type X collagen [4 out of 4 samples were negative. The positive 
area was 0 ± 0%. The area of fracture + SCI group was smaller than that of fracture 
group (p < 0.05)] immunostaining was observed in the fracture callus of the fracture + 
SCI rats. The immunohistochemical detection of type II and type X collagen provides a 
molecular marker distinguishing between bone formed by intramembranous and 
endochondral ossification. These results indicated that the newly formed bone in the 
fracture + SCI group at 7 days was intramembranous bone. On the other hand, we 
observed immunoreactivity to type I collagen (4 out of 4 samples were positive. The 
positive area was 73.2 ± 9.6%.), type II collagen (4 out of 4 samples were positive. The 
positive area was 17.5 ± 3.3%.), and X collagen (4 out of 4 samples were positive. The 
positive area was 3.1 ± 1.5%.) found in the fracture callus of the fractured rats. The 
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results indicated that the newly formed bone in the fracture group was both 
intramembranous and endochondral bone. At 14 days, the immunoreactivity to type I 
collagen (fracture + SCI group, 4 out of 4 samples were positive. The positive area was 
25.9 ± 13.5%; fracture group, 4 out of 4 samples were positive. The positive area was 
27.9 ± 22.3%. No significant difference was found between groups.), type II collagen 
(fracture + SCI group, 4 out of 4 samples were positive. The positive area was 20.4 ± 
6.2%; fracture + SCI group, 4 out of 4 samples were positive. The positive area was 
43.9 ± 20.7%. No significant difference was found between groups.), and type X 
collagen (fracture + SCI group, 4 out of 4 samples were positive. The positive area was 
5.7 ± 3.2%; fracture group, 4 out of 4 samples were positive. The positive area was 11.5 
± 7.6%. No significant difference was found between groups.) was observed in the 
callus of the fracture and fracture + SCI groups. These results indicated that both the 
intramembranous and endochondral ossification occurred in both the fracture and 
fracture + SCI groups (Fig. 5).  
 Positive immunolabeling for CD68 was observed in the fractured callus of the 
fracture and fracture + SCI rats at 7 days. The degree of immunoreactivity in the callus 
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of the fracture + SCI rats was lower than that of the fractured rats. At 14, 28, and 49 
days, both the groups exhibited the same level of immunoreactivity for CD68 at the 
surface of the newly formed bone (Fig. 6).  
Mechanical Testing  
The ultimate loads at failure in the control, fracture, SCI, and fracture + SCI groups 
were 152.00 ± 17.62, 140.84 ± 60.13, 90.00 ± 22.05, and 105.58 ± 7.12 N, respectively. 
The bone strength in the fracture group recovered to the same level as that of the control 
group. Similarly, the bone strength of the fracture + SCI group returned to the same 
level as that of the SCI group. However, the bone strength of the SCI and fracture + SCI 
groups was significantly lower than that of the control group (p < 0.05), and this result 
showed that the bones of the SCI and fracture + SCI groups were weak in comparison to 
that of the control group. The stiffness in the control, fracture, SCI, and fracture + SCI 
groups were 249.88 ± 59.96, 114.96 ± 32.62, 205.77 ± 15.67, and 88.94 ± 15.73 N/m, 
respectively. The stiffness in the fracture group was significantly lower than that in the 
control and SCI groups (p < 0.05). The stiffness in the fracture + SCI group was 
significantly lower than that in the SCI group (p < 0.01). The energy-to-failure in the 
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control, fracture, SCI, and fracture + SCI groups were 320.46 ± 35.35, 239.10 ± 12.59, 
110.71 ± 14.83, and 121.11 ± 31.12 mJ, respectively. The energy-to-failure in  
the fracture group returned to the same level as that in the control group. The energy-to-
failure in the fracture + SCI group returned to the same level as that of the SCI group. 
However, the energy-to-failure in the fracture + SCI group and SCI groups was 
significantly lower than that in the control group (p < 0.01).  
 
Discussion  
The aims of this study were to determine whether fractures with SCI heal earlier in 
terms of their morphological and mechanical properties than normal fractures, to 
characterize the process of accelerated fracture healing with SCI, and to clarify the 
factors responsible for accelerated fracture healing. Similar to a previous studies of 
humans [5, 7] and animals [11, 13, 14], in the present study the acceleration of fracture 
healing with SCI was confirmed. This is because the SCI fractures exhibited a rapid and 
full recovery of bone morphology and the same degree of functional recovery of the 
bones after SCI. Eventually, we found that SCI fractures led to an approximately 40% 
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decrease in the time for the synchrotron radiographic healing of femoral fractures, in 
which the SCI fractures healed in 28 days, rather than the 49 days in the fracture group. 
We also found that the fracture after SCI in the early phase predominantly healed 
through intramembranous ossification, whereas that of the normal fractures through 
both intramembranous and endochondral ossifications. In addition, the time required for 
the completion of endochondral ossification in SCI fracture was shorter than that in 
normal fracture. Therefore, the accelerated fracture healing with SCI may be due to 
predominant intramembranous ossification and promoting endochondral ossification. 
Furthermore, the present findings may shed light on what’s underlying this phenomenon 
and provide evidence that muscle contraction by spasticity contributes to the 
acceleration of fracture healing after SCI. The accelerated fracture healing was 
attenuated in SCI fracture treated with BTX, and therefore this result indicates that 
mechanical stress by spasticity has significant roles in accelerated fracture healing with 
SCI.  
 We have demonstrated that the morphological recovery of a fractured bone in 
the fracture + SCI rats was faster than that in the fracture rats. The SR-µCT analysis 
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showed that the bony bridging of the fracture gap occurred earlier in the fracture + SCI 
rats than in the fracture rats. µCT is a more sensitive tool for detecting changes that 
occur during fracture healing than X-rays that were used in the previous studies. In 
addition, SR-µCT provides superior resolution to µCT. Thus, we could evaluate the 
morphological differences in the healing process in greater detail. These date are 
consistent with histologic and histomorphometric analyses, which revealed that the 
cortical bridging fracture union was more rapid in the fracture + SCI rats than in the 
fractured rats. The newly formed bone after the fracture recovers generally the original 
bony shape and strength through remodeling immature woven bone into mature cortical 
bone. The fracture healing score of fractures with SCI exhibited a significantly higher 
score at 28 days. Collectively, these results demonstrated that SCI accelerated the 
recovery of the bone morphology after the fracture. 
 Our mechanical testing indicates that the strength and energy-to-failure of 
healed bone with SCI returned to the same level as that of non-fractured bone with SCI. 
Nonetheless, the healed bone with SCI was more fragile than the healthy control bone. 
The loss of bone strength induced by bone loss after SCI has been well documented in 
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animal studies [40-43]. Therefore, the weakness of SCI fractures may be attributed to 
bone atrophy after SCI.  
 Fractured bone commonly heals through the following stages: (1) 
inflammation; (2) callus formation; and (3) remodeling. In the inflammatory stage, 
inflammatory cells such as macrophages ingest necrotic tissue after the fracture. The 
newly formed bone was formed by endochondral ossification and intramembranous 
ossification, and endochondral ossification predominates in the callus formation stage. 
In the remodeling stage, the newly formed bone is remodeled into the pre-fractured 
bone shape. According to histomorphometry and immunohistochemistry for type I, II, 
and X collagen, both the intramembranous and endochondral ossification occurred in 
the fracture group. However, SCI fractures exhibited only intramembranous ossification 
in the callus at 7 days corresponding to the stage of inflammation or callus formation. 
At 14 days, the intramembranous and endochondral ossification occurred in the fracture 
and fracture + SCI groups. However, the endochondral ossification phase in SCI 
fracture was shorter than that in normal fracture, because the start of endochondral 
ossification in SCI fracture was late. In addition, these changes might be reflected in a 
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decrease in the callus size in the fracture + SCI rats. Taken together, SCI fracture 
healing was characterized by the formation of callus with predominant 
intramembranous ossification and promoting endochondral ossification. The 
characteristic callus formation after SCI may contribute to accelerated fracture healing. 
Intramembranous ossification does not involve formation of intermediate cartilaginous 
tissue, while endochondral ossification involves formation and subsequent remodeling 
of cartilage to bone tissue. The formation and subsequent remodeling of cartilage to 
bone tissue requires long time. Therefore, the change of ossification pattern from 
endochondral ossification to intramembranous ossification can lead to rapid bone 
formation, and thus the bony union of fracture site could be achieved early. The stability 
of the fracture fixation affects the ossification pattern in healing fracture [44]. We used 
intramedullary nailing developed by Einhorn et al. [31] as the fixation of fracture. The 
fixation method has some limitations with regards to fracture stability; unlocked 
intramedullary rod does not provide a resistance to torsional and weight bearing. 
Therefore, SCI-induced non-weight loading may affect the change of ossification 
pattern. However, Aro et al. [13]. contributed to this possibility using hip dislocation-
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induced non-weight loading model. The change of fracture healing process associated 
with SCI is not simply due to a reduction in weight loading as postulated by Aro et al.. 
Additionally, the immunohistology analysis in the fracture callus of the fracture + SCI 
rats revealed fewer macrophages at 7 days after the fracture. Macrophages have been 
associated with cartilage formation, and a decrease in macrophage-impaired cartilage 
maturation [45]. Therefore, the change in ossification may result from a decrease in the 
number of macrophages.  
 The present study attempted to verify the hypothesis that spasticity and/or 
sympathetic overactivity contribute to accelerated fracture healing in SCI rats. 
Consequently, the accelerated fracture healing after SCI was canceled out by BTX 
injection, but did not change by propranolol. The intramuscular administration of BTX 
attenuates a spastic muscle’s ability to generate mechanical stress by muscle 
contraction. The present results suggest that increased muscle contraction caused by 
spasticity accelerated fracture healing after SCI. A recent report disclosed that muscle 
contraction elicited by electrical stimulation protects against SCI-related bone loss, and 
that muscle contraction can increase mechanical stress on bone and lead to increased 
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bone volume [18]. Additionally, the importance of muscle-derived mechanical stress for 
bone healing was confirmed by the work of Hao et al. [19] that evaluated the effect of 
muscle paralysis on normal femoral fracture healing. Paralysis of quadriceps muscle by 
administration of BTX negatively impacted the healing capacity of femoral fractures in 
rats. Our findings not only provide new insights into fracture healing process after SCI, 
but also raise intriguing possibilities for the use of muscle contraction to accelerate 
fracture healing.  
 Although novel therapies for fracture healing are constantly explored, 
effective therapeutic approaches have not been established in clinical settings. Our 
findings indicate that the acceleration of fracture healing in rats with SCI ultimately 
leads to new therapeutic strategies that accelerate fracture healing. However, a potential 
weakness of our results is that the strength of the healed bone with SCI did not return to 
the same level as control bones.  
 In conclusion, we found that the fracture with SCI healed earlier than a 
normal fracture in terms of both morphology and strength. Furthermore, our results 
indicate that accelerated fracture healing with SCI was due to predominant 
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intramembranous ossification and promoting endochondral ossification. Our results also 
suggest that the muscle contraction by spasticity is an important factor responsible for 
accelerated fracture healing after SCI.  
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Figure legends 
Fig. 1 Representative 3D images during fracture healing. The fracture gap in the 
fracture + SCI, BTX, and propranolol groups disappeared earlier than that of the 
fracture group did, and the bony union was observed earlier in these groups than that of 
the fracture group. The white arrowheads indicate the fracture gap 
Fig. 2 The callus size of the fracture and fracture + SCI groups during fracture healing. 
The size of callus in the fracture + SCI group was significantly smaller than that of the 
fracture group at all the time points. *p < 0.05  
Fig. 3 a Representative safranin-O-stained histological images of the fracture and 
fracture + SCI groups during fracture healing. The complete bridging of the fracture gap 
occurred earlier in the fracture + SCI group than that in the fracture group. Cb cortical 
bone, Ca cartilage tissue, Wb woven bone tissue. Scale bars 1 mm. b The temporal 
changes in the fibrous tissue area, cartilage tissue area, and newly formed bone area in 
the fracture callus of the fracture and fracture + SCI rats during fracture healing. At 7 
days, the area of cartilage tissue in the fracture + SCI group was significantly smaller 
than that of the fracture group. *p < 0.05  
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Fig. 4 Representative safranin-O-stained histological images of the fracture, fracture + 
SCI, BTX, and propranolol groups at 14 and 28 days after fracture. The bony bridging 
of fracture gap in the BTX group occurred with immature woven bone, although no 
difference between the fracture + SCI and propranolol groups was observed. Cb cortical 
bone, Ca cartilage tissue, Wb woven bone tissue. Scale bars 1 mm  
Fig. 5 Representative immunostaining images for type I, II, and X collagen of the 
fracture and fracture + SCI groups during fracture healing. At 7 days, the 
immunoreactivity of type I, II, and X collagen was observed in the callus of fractured 
rats. In contrast, the immunoreactivity of type I collagen was observed in the callus of 
fracture + SCI rats. At 14 days, the immunoreactivity of type I, II, and X collagen was 
observed in the callus of the fracture and fracture + SCI rats. The black arrows indicate 
immunoreactivity of type I collagen. The black arrowheads indicate the 
immunoreactivity of type II collagen. The white arrows indicate the immunoreactivity 
of type X collagen. Scale bar 500 µm  
Fig. 6 Representative immunostaining images for CD68 of the fracture and fracture + 
SCI groups during fracture healing. The immunoreactivity of the fracture + SCI group 
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was lower than that of the fracture group. The black arrowheads indicate the 
immunoreactivity of CD68. Scale bar 1 mm  
Supplemental Fig. 1 Study design with the assignment of animals to each group and 
the timeline of analyses. 
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